st 587 has been researched along with nimodipine in 1 studies
| Studies (st 587) | Trials (st 587) | Recent Studies (post-2010) (st 587) | Studies (nimodipine) | Trials (nimodipine) | Recent Studies (post-2010) (nimodipine) |
|---|---|---|---|---|---|
| 67 | 0 | 0 | 2,936 | 317 | 597 |
| Protein | Taxonomy | st 587 (IC50) | nimodipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 0.11 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.19 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 1.736 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 3.38 | |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | 0.0298 | |
| Voltage-dependent L-type calcium channel subunit beta-2 | Homo sapiens (human) | 0.0298 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 7.15 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 0.0699 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 1.243 | |
| Bile acid receptor | Homo sapiens (human) | 8.96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooke, JP; Flavahan, NA; Rimele, TJ; Vanhoutte, PM | 1 |
1 other study(ies) available for st 587 and nimodipine
| Article | Year |
|---|---|
Nimodipine and inhibition of alpha adrenergic activation of the isolated canine saphenous vein.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Calcium Channel Blockers; Clonidine; Dogs; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Nicotinic Acids; Nimodipine; Potassium; Receptors, Adrenergic, alpha; Saphenous Vein; Tyramine; Vasoconstriction | 1985 |